TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/16/24 18:06 | 1/11/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Given Douglas B | CA | D | S | -111 | 38.06 | 0 | -3 | -2 | 130 | D | |||||||||||||||
5/8/23 18:29 | 5/5/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Given Douglas B | CA | D | S | -266 | 40.90 | 0 | -7 | -4 | 143 | D | |||||||||||||||
3/1/23 18:14 | 2/27/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Given Douglas B | CA | D | S | -29 | 32.62 | 0 | -1 | -1 | 150 | I | |||||||||||||||
12/29/21 20:44 | 12/28/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Given Douglas B | CA | D | P | 43 | 66.37 | 0 | 1 | 0 | 136 | D | |||||||||||||||
9/10/21 16:53 | 9/9/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Given Douglas B | CA | D | S | -326 | 65.24 | 0 | -5 | -4 | 136 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |